Agios Pharmaceuticals AGIO
NASDAQ AGIO
$33.10 -0.03 (-0.09%)
As of: Sep 4, 2026 · 3:59 PM EDT

Agios Pharmaceuticals (AGIO) EBT Margin (QoQ) (2012 - 2026)

Analysis

Agios Pharmaceuticals (AGIO) EBT Margin (QoQ) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Agios Pharmaceuticals 1.97 Bn 1.97 Bn 41.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25,298.00
Mar 31, 2026 6,787.00
Dec 31, 2025 25,688.00
Sep 30, 2025 10,055.00
Jun 30, 2025 13,401.00
Mar 31, 2025 -5,533.00
Dec 31, 2024 -1.21 Mn
Sep 30, 2024 1.23 Mn
Jun 30, 2024 -11,824.00
Mar 31, 2024 33,491.00
Dec 31, 2023 -11,642.00
Sep 30, 2023 3,876.00
Jun 30, 2023 19,821.00
Mar 31, 2023 67,920.00
Dec 31, 2022 33,170.00
Sep 30, 2022 -76,507.00
Jun 30, 2022 1.04 Mn
Dec 31, 2020 3,619.00
Sep 30, 2020 -992.00
Jun 30, 2020 -12,166.00